Published in Clin Res Cardiol on November 03, 2011
Ivabradine: potential clinical applications in critically ill patients. Clin Res Cardiol (2012) 0.92
Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic. Clin Res Cardiol (2013) 0.85
Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol (2013) 0.83
Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure. Clin Res Cardiol (2012) 0.83
I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes. J Mol Cell Cardiol (2014) 0.80
Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness. Clin Res Cardiol (2013) 0.78
Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients. Clin Res Cardiol (2014) 0.75
Advances in the management of heart failure: the role of ivabradine. Vasc Health Risk Manag (2016) 0.75
Increased heart rate on first day in Intensive Care Unit is associated with increased mortality. Pak J Med Sci (2017) 0.75
Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clin Res Cardiol (2014) 0.75
Electrical myostimulation improves left ventricular function and peak oxygen consumption in patients with chronic heart failure: results from the exEMS study comparing different stimulation strategies. Clin Res Cardiol (2013) 0.75
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 5.03
Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg (1992) 4.50
Resting heart rate in cardiovascular disease. J Am Coll Cardiol (2007) 4.14
Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med (1996) 3.61
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet (2010) 2.80
The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med (2011) 2.08
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med (2005) 1.99
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J (2007) 1.89
Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med (2005) 1.88
Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med (2009) 1.85
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med (2010) 1.84
Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med (2005) 1.73
Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit Care Med (2008) 1.66
Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med (2001) 1.65
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med (2009) 1.56
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation (2004) 1.55
Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock. Chest (1999) 1.46
Relationship of changes in cardiac output to changes in heart rate in medical ICU patients. Intensive Care Med (1996) 1.43
Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol (2006) 1.36
Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34
Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med (2010) 1.30
Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol (1990) 1.25
Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol (2009) 1.16
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med (2006) 1.15
Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med (2005) 1.13
Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med (2007) 1.12
Endotoxin impairs the human pacemaker current If. Shock (2007) 1.10
Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol (2010) 1.08
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care (2008) 1.07
Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther (2003) 1.05
Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth (2001) 0.99
Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med (2002) 0.99
Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial. Clin Res Cardiol (2011) 0.96
Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors. Intensive Care Med (1995) 0.94
Cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in LPS-treated rats. Crit Care (2009) 0.92
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail (2008) 0.88
Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study. Eur Heart J (1998) 0.88
Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol (1998) 0.86
Ultimate survival from septic shock. Resuscitation (1986) 0.86
Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery. Clin Res Cardiol (2010) 0.86
Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction. Trends Cardiovasc Med (2009) 0.85
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure. Clin Res Cardiol (2009) 0.84
Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM (2007) 0.82
Measures of parasympathetic function and risk stratification in critical care. Crit Care Med (2008) 0.78
Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. Clin Res Cardiol (2010) 0.78
How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure. Med Hypotheses (2009) 0.77
Ivabradine for the treatment of stable angina pectoris in octogenarians. Clin Res Cardiol (2010) 0.76
Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock. Infection (1991) 0.75
[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]. Dtsch Med Wochenschr (2008) 0.75
[Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1]. Kardiol Pol (2010) 0.75
Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med (2012) 9.22
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer (2010) 3.11
Rehabilitation in Patients With Coronary Heart Disease: Participation and Its Effect on Prognosis. Dtsch Arztebl Int (2015) 2.69
Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Crit Care Med (2009) 2.16
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med (2005) 1.99
Intravascular embolization of venous catheter--causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr (2009) 1.94
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol (2013) 1.89
Mirror, mirror on the wall, which is the fairest meta-analysis of all? Crit Care Med (2007) 1.86
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med (2010) 1.84
Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med (2004) 1.72
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet (2002) 1.69
Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit Care Med (2008) 1.66
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J (2012) 1.65
Mechanical circulatory support in cardiogenic shock. Eur Heart J (2013) 1.64
Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg (2005) 1.53
Transcoronary pacing in a porcine model--impact of guidewire insulation. J Invasive Cardiol (2011) 1.42
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med (2008) 1.42
Disseminated intravascular coagulation: a matter for immune globulins in sepsis? Crit Care Med (2006) 1.41
Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med (2012) 1.41
Cyclosporine area under the curve after allogeneic hematopoietic stem cell transplantation is an indicator of Epstein-Barr virus DNAemia. Leuk Lymphoma (2012) 1.40
Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol (2006) 1.36
Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord (2005) 1.33
Communication of end-of-life decisions in European intensive care units. Intensive Care Med (2005) 1.28
Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med (2003) 1.25
Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet (2010) 1.23
Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. Eur J Epidemiol (2009) 1.22
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab (Lond) (2006) 1.20
Prevention and health promotion in undergraduate medical education: Preferences, attitudes and previous knowledge of medical students - a cross-sectional study. GMS Z Med Ausbild (2011) 1.18
Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? Dtsch Arztebl Int (2009) 1.18
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility. Cardiovasc Res (2006) 1.16
Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol (2009) 1.16
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med (2006) 1.15
Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells (2006) 1.13
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun (2008) 1.13
Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med (2007) 1.12
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res (2003) 1.10
Endotoxin impairs the human pacemaker current If. Shock (2007) 1.10
Activation of myogenic differentiation pathways in adult bone marrow-derived stem cells. Mol Cell Biol (2005) 1.09
Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol (2003) 1.06
Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications. Clin Res Cardiol (2011) 1.04
Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock (2008) 1.03
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study. Clin Res Cardiol (2012) 1.02
Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics (2007) 1.01
Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med (2002) 0.99
Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res (2005) 0.99
Mandibular jaw movement capacity in 10-17-yr-old children and adolescents: normative values and the influence of gender, age, and temporomandibular disorders. Eur J Oral Sci (2006) 0.99
Association of childhood and adult socioeconomic indicators with cardiovascular risk factors and its modification by age: the CARLA Study 2002-2006. BMC Public Health (2011) 0.98
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. Oncogene (2005) 0.98
Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS One (2013) 0.97
Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial. Clin Res Cardiol (2011) 0.96
Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival. Lung Cancer (2008) 0.96
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev (2015) 0.95
The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors. Langenbecks Arch Surg (2004) 0.95
Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch (2004) 0.94
Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci Rep (2002) 0.94
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev (2011) 0.94
Regional differences in body fat distributions among people with comparable body mass index: a comparison across six German population-based surveys. Eur J Cardiovasc Prev Rehabil (2011) 0.94
The importance of genetic variants in TNFα for periodontal disease in a cohort of coronary patients. J Clin Periodontol (2012) 0.94
Impedance cardiography: a useful and reliable tool in optimization of cardiac resynchronization devices. Europace (2007) 0.93
Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. Mol Med (2007) 0.93
Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res (2009) 0.92
Chemo- and ergoreflexes in health, disease and ageing. Int J Cardiol (2005) 0.92
Intraaortic balloon support for cardiogenic shock. N Engl J Med (2013) 0.91
Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients. BMC Cancer (2012) 0.90
Association of occupation with prevalent hypertension in an elderly East German population: an exploratory cross-sectional analysis. Int Arch Occup Environ Health (2010) 0.90
Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin. J Endotoxin Res (2007) 0.90
Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains. J Physiol (2013) 0.90
Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. J Mol Cell Cardiol (2010) 0.90
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J (2009) 0.89
Embolic events caused by aortic thrombi: an underestimated entity? J Thromb Thrombolysis (2013) 0.89
Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. Gynecol Oncol (2004) 0.88